OpenAlex
PricingAboutJobs
Log inGet started
Work

Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: A double-blind, randomized pilot study

HTML

Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Affective Disorders
DOI: 10.1016/j.jad.2013.02.003
Authors: Jose A. Franco-Chaves, Camilo F. Mateus, David A. Luckenbaugh, Pedro E. Martinez, Alan G. Mallinger, Carlos A. Zarate
Institutions: National Institutes of Health, National Institute of Mental Health, United States Department of Veterans Affairs, Office of Inspector General
Language: English

Topic: Treatment of Major Depression
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: major depressive disorder, pramipexole, escitalopram, dopamine agonists, selective serotonin reuptake inhibitors, antidepressant combination therapy, antidepressant efficacy, treatment discontinuation, drug tolerability, treatment-resistant depression
SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, U.S. Public Health Service, National Institute of Mental Health
Awards: G1809954298, G22704215, Comb Dopamine Agonist & Select Serotonin Reuptake Inhibitor f/Trtmt of Depression, Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders
OpenAlex ID: W1984052858
FWCI: 1.927
Cites: 49
Cited by: 42
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security